Q4 2024 · 13F-HR
ADAR1 Capital Management, LLCholdings as filed
Filed 2025-02-13 · accession 0001940272-25-000001
$500.4M
Reported value
214
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $41.5M | 8.30% | 3,508,694 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $39.4M | 7.87% | 1,020,333 | Common | SOLE |
| 02072L565 | BOXX | EA SERIES TRUST | $35.9M | 7.17% | 325,450 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $27.4M | 5.47% | 1,045,837 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $19.5M | 3.90% | 787,478 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $19.5M | 3.89% | 414,209 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $18.6M | 3.72% | 678,857 | Common | SOLE |
| 45719W205 | IKT | INHIBIKASE THERAPEUTICS INC | $16.6M | 3.31% | 5,103,005 | Common | SOLE |
| 78468R663 | BIL | SPDR SER TR | $12.0M | 2.41% | 131,786 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $11.1M | 2.21% | 1,513,393 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $10.4M | 2.07% | 841,541 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $9.8M | 1.96% | 71,402 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $7.6M | 1.53% | 750,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $7.4M | 1.49% | 170,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $6.7M | 1.33% | 1,359,208 | Common | SOLE |
| 29260Y109 | 0C3 | ENDEAVOR GROUP HLDGS INC | $6.6M | 1.32% | 210,729 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $6.2M | 1.24% | 215,750 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $5.9M | 1.17% | 1,052,968 | Common | SOLE |
| G1000R101 | AAM | AA MISSION ACQUISITION CORP | $5.7M | 1.13% | 560,199 | Common | SOLE |
| 19249HAB9 | — | COHERUS BIOSCIENCES INC | $5.5M | 1.09% | 5,625,000 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $5.4M | 1.08% | 234,607 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $5.2M | 1.04% | 2,077,251 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $5.1M | 1.02% | 132,000 | CALL | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $5.1M | 1.02% | 1,554,802 | Common | SOLE |
| G6717R120 | OACCU | OAKTREE ACQUISITION CORP III | $5.1M | 1.01% | 500,000 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $4.9M | 0.97% | 40,002 | Common | SOLE |
| 80105N105 | SNY | SANOFI | $4.8M | 0.96% | 99,600 | Common | SOLE |
| 78464A870 | XBI | SPDR SER TR | $4.5M | 0.90% | 50,000 | CALL | SOLE |
| 38341PAA0 | GOSS 5 06/01/27 | GOSSAMER BIO INC | $4.4M | 0.87% | 8,000,000 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $4.2M | 0.85% | 404,138 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $4.0M | 0.81% | 515,138 | Common | SOLE |
| 10806XAD4 | BBIO 2.25 02/01/29 | BRIDGEBIO PHARMA INC | $3.9M | 0.77% | 4,500,000 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $3.4M | 0.68% | 81,460 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $3.3M | 0.66% | 166,406 | Common | SOLE |
| 01438T106 | ALDX | ALDEYRA THERAPEUTICS INC | $3.2M | 0.65% | 647,960 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $3.2M | 0.65% | 146,671 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $3.0M | 0.61% | 988,468 | Common | SOLE |
| 00439U104 | GRCE | GRACE THERAPEUTICS INC | $2.9M | 0.58% | 773,635 | Common | SOLE |
| 61023L207 | MNPR | MONOPAR THERAPEUTICS INC | $2.9M | 0.57% | 130,037 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $2.7M | 0.54% | 53,125 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $2.7M | 0.54% | 58,708 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $2.7M | 0.53% | 211,400 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $2.6M | 0.52% | 154,027 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $2.5M | 0.49% | 928,016 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $2.2M | 0.44% | 57,978 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $2.2M | 0.43% | 48,023 | Common | SOLE |
| G0544A137 | ASPCU | A SPAC III ACQUISITION CORP | $2.2M | 0.43% | 215,000 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $2.1M | 0.42% | 2,000,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $2.0M | 0.40% | 50,547 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $1.9M | 0.37% | 41,274 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $1.9M | 0.37% | 1,174,313 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $1.8M | 0.36% | 149,385 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $1.8M | 0.35% | 134,798 | Common | SOLE |
| 697947109 | PVLA | PALVELLA THERAPEUTICS INC NE | $1.7M | 0.35% | 144,641 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $1.7M | 0.35% | 30,941 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $1.7M | 0.34% | 31,509 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $1.7M | 0.33% | 19,661 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $1.7M | 0.33% | 36,830 | Common | SOLE |
| 483119202 | KALAEUR | KALA BIO INC | $1.5M | 0.31% | 220,373 | Common | SOLE |
| G33033104 | KDK | ARES ACQUISITION CORP II | $1.5M | 0.30% | 138,966 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $1.5M | 0.30% | 21,974 | Common | SOLE |
| 05368M106 | PPHMEUR | AVID BIOSERVICES INC | $1.5M | 0.30% | 120,000 | Common | SOLE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $1.4M | 0.29% | 10,000 | CALL | SOLE |
| 00445A100 | — | ACELYRIN INC | $1.4M | 0.28% | 444,967 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $1.4M | 0.27% | 29,100 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $1.3M | 0.26% | 170,129 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $1.3M | 0.26% | 95,000 | CALL | SOLE |
| 73730P108 | PSTXUSD | POSEIDA THERAPEUTICS INC | $1.3M | 0.26% | 134,109 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA PLC | $1.3M | 0.25% | 49,963 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $1.2M | 0.24% | 82,234 | Common | SOLE |
| 02074J501 | ACOG | ALPHA COGNITION INC | $1.2M | 0.24% | 204,348 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $1.2M | 0.24% | 337,676 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $1.1M | 0.22% | 169,505 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $1.0M | 0.21% | 1,350 | Common | SOLE |
| 451033708 | IBIO | IBIO INC | $1.0M | 0.20% | 415,606 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $1.0M | 0.20% | 131,599 | Common | SOLE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $990,555 | 0.20% | 147,404 | Common | SOLE |
| 68218J103 | OABI | OMNIAB INC | $984,502 | 0.20% | 278,108 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $969,481 | 0.19% | 1,361 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $957,851 | 0.19% | 35,319 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $950,138 | 0.19% | 38,312 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $943,510 | 0.19% | 17,424 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $929,876 | 0.19% | 35,050 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $922,366 | 0.18% | 196,248 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $918,200 | 0.18% | 4,000 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $913,554 | 0.18% | 44,826 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $843,006 | 0.17% | 19,505 | Common | SOLE |
| G0131Y100 | ANSC | AGRICULTURE & NAT SOL ACQ CO | $842,997 | 0.17% | 80,362 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $825,315 | 0.16% | 801,277 | Common | SOLE |
| G52443101 | KVACU | KEEN VISION ACQUISITION CORP | $824,250 | 0.16% | 75,000 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $813,397 | 0.16% | 90,984 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $774,456 | 0.15% | 56,120 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $727,245 | 0.15% | 68,608 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $718,911 | 0.14% | 126,792 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $712,384 | 0.14% | 123,037 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $710,304 | 0.14% | 15,100 | CALL | SOLE |
| 014442107 | ALEC | ALECTOR INC | $696,144 | 0.14% | 368,330 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $682,399 | 0.14% | 2,900 | Common | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $671,929 | 0.13% | 54,057 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $671,801 | 0.13% | 53,023 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $670,333 | 0.13% | 24,938 | Common | SOLE |
| 49721T507 | KPRX | KIORA PHARMACEUTICALS INC | $660,729 | 0.13% | 200,221 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $647,803 | 0.13% | 122,690 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $625,950 | 0.13% | 22,500 | CALL | SOLE |
| 45783C200 | TIL | INSTIL BIO INC | $605,306 | 0.12% | 31,708 | Common | SOLE |
| 68622V106 | OGN | ORGANON & CO | $599,784 | 0.12% | 40,200 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $595,612 | 0.12% | 148,903 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $549,328 | 0.11% | 2,974 | Common | SOLE |
| 97717Y527 | USFR | WISDOMTREE TR | $503,200 | 0.10% | 10,000 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $498,420 | 0.10% | 26,000 | Common | SOLE |
| 80810D103 | SDGR | SCHRODINGER INC | $485,086 | 0.10% | 25,147 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $478,650 | 0.10% | 15,000 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $470,252 | 0.09% | 64,067 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $465,641 | 0.09% | 3,045 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $453,957 | 0.09% | 530,324 | CALL | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $449,848 | 0.09% | 55,400 | Common | SOLE |
| G6363K106 | — | NABORS ENERGY TRANSITION COR | $430,920 | 0.09% | 39,900 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $425,841 | 0.09% | 15,307 | Common | SOLE |
| 16934W106 | CMRXEUR | CHIMERIX INC | $425,381 | 0.09% | 122,236 | Common | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $413,082 | 0.08% | 157,665 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $402,300 | 0.08% | 10,000 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $385,489 | 0.08% | 17,683 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $374,232 | 0.07% | 9,300 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $374,220 | 0.07% | 9,000 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $368,649 | 0.07% | 351,094 | Common | SOLE |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $368,500 | 0.07% | 110,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $367,984 | 0.07% | 23,246 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $361,465 | 0.07% | 27,301 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $358,310 | 0.07% | 121,461 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $336,560 | 0.07% | 8,000 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $328,650 | 0.07% | 5,000 | CALL | SOLE |
| G5212E105 | — | JVSPAC ACQUISITION CORP | $312,600 | 0.06% | 30,000 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $307,433 | 0.06% | 177,707 | Common | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $304,750 | 0.06% | 106,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $303,846 | 0.06% | 3,962 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $303,590 | 0.06% | 35,843 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $293,007 | 0.06% | 10,188 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $280,950 | 0.06% | 5,000 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $276,850 | 0.06% | 5,000 | CALL | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $272,721 | 0.05% | 124,530 | Common | SOLE |
| L01800108 | ALVO | ALVOTECH | $272,538 | 0.05% | 20,600 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $268,429 | 0.05% | 21,700 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $267,412 | 0.05% | 295,613 | Common | SOLE |
| 22053A107 | — | QUINCE THERAPEUTICS INC | $267,331 | 0.05% | 142,958 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $266,026 | 0.05% | 4,196 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $263,200 | 0.05% | 35,000 | Common | SOLE |
| 462837105 | UCFI | IRON HORSE ACQUISITIONS CORP | $257,250 | 0.05% | 25,000 | Common | SOLE |
| 75989R107 | RNXT | RENOVORX INC | $254,452 | 0.05% | 197,250 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $243,443 | 0.05% | 80,080 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $242,731 | 0.05% | 2,440 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $242,520 | 0.05% | 12,900 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $235,815 | 0.05% | 23,700 | Common | SOLE |
| 88338N206 | TXMD | THERAPEUTICSMD INC | $232,338 | 0.05% | 270,160 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $214,750 | 0.04% | 34,693 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $211,348 | 0.04% | 76,299 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $207,240 | 0.04% | 11,000 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $191,621 | 0.04% | 28,221 | Common | SOLE |
| 37611X209 | DNA | GINKGO BIOWORKS HOLDINGS INC | $183,438 | 0.04% | 18,680 | Common | SOLE |
| 015857105 | AQN | ALGONQUIN PWR UTILS CORP | $178,000 | 0.04% | 40,000 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $176,600 | 0.04% | 10,000 | Common | SOLE |
| 15117F807 | CLRBUSD | CELLECTAR BIOSCIENCES INC | $174,993 | 0.03% | 585,261 | Common | SOLE |
| 032797300 | AVXL | ANAVEX LIFE SCIENCES CORP | $174,214 | 0.03% | 16,221 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $174,000 | 0.03% | 25,000 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $169,561 | 0.03% | 403,716 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $162,186 | 0.03% | 94,294 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $157,347 | 0.03% | 31,035 | Common | SOLE |
| G1148A101 | BKHA | BLACK HAWK ACQUISITION CORP | $155,700 | 0.03% | 15,000 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $152,522 | 0.03% | 101,008 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $149,387 | 0.03% | 145,036 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $137,594 | 0.03% | 17,800 | CALL | SOLE |
| N0731H103 | ATAI | ATAI LIFE SCIENCES NV | $133,000 | 0.03% | 100,000 | Common | SOLE |
| G1933S101 | CASIF | CASI PHARMACEUTICALS INC | $131,086 | 0.03% | 46,320 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $131,081 | 0.03% | 244,966 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $123,840 | 0.02% | 18,000 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $121,878 | 0.02% | 130,532 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $116,180 | 0.02% | 15,700 | Common | SOLE |
| 03212B103 | AMPY | AMPLIFY ENERGY CORP NEW | $110,850 | 0.02% | 18,475 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $110,052 | 0.02% | 533,200 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $104,256 | 0.02% | 19,200 | Common | SOLE |
| 62459M206 | — | MOVANO INC | $103,388 | 0.02% | 19,146 | Common | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $101,400 | 0.02% | 15,000 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $92,529 | 0.02% | 120,012 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $86,625 | 0.02% | 48,125 | Common | SOLE |
| 38000Q102 | GLYCEUR | GLYCOMIMETICS INC | $82,625 | 0.02% | 331,827 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $82,012 | 0.02% | 10,100 | CALL | SOLE |
| 00534B100 | ADGM | ADAGIO MED HLDGS INC | $80,595 | 0.02% | 76,757 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $80,250 | 0.02% | 15,000 | PUT | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $75,339 | 0.02% | 62,264 | Common | SOLE |
| 18914F103 | CLOV | CLOVER HEALTH INVESTMENTS CO | $73,395 | 0.01% | 23,300 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $65,920 | 0.01% | 16,000 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $63,011 | 0.01% | 67,754 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $54,044 | 0.01% | 20,394 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $53,500 | 0.01% | 10,000 | CALL | SOLE |
| 004468500 | ACHV | ACHIEVE LIFE SCIENCES INC | $46,369 | 0.01% | 13,173 | Common | SOLE |
| 00288U106 | ABCL | ABCELLERA BIOLOGICS INC | $43,894 | 0.01% | 14,981 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $37,800 | 0.01% | 10,000 | CALL | SOLE |
| G1000R127 | — | AA MISSION ACQUISITION CORP | $35,357 | 0.01% | 505,099 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $35,000 | 0.01% | 10,000 | Common | SOLE |
| 92536C103 | VERUEUR | VERU INC | $32,995 | 0.01% | 50,722 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $26,423 | 0.01% | 15,543 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $18,000 | 0.00% | 19,898 | CALL | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $15,600 | 0.00% | 10,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $13,526 | 0.00% | 20,000 | Common | SOLE |
| 37962G128 | — | GLOBAL STAR ACQUISITION INC | $13,275 | 0.00% | 88,560 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $12,864 | 0.00% | 13,400 | Common | SOLE |
| G5212E113 | — | JVSPAC ACQUISITION CORP | $8,868 | 0.00% | 30,000 | Common | SOLE |
| 462837121 | — | IRON HORSE ACQUISITIONS CORP | $6,950 | 0.00% | 25,000 | Common | SOLE |
| 37962G110 | — | GLOBAL STAR ACQUISITION INC | $3,612 | 0.00% | 120,000 | Common | SOLE |
| G3034H141 | EMCRF | EMBRACE CHANGE ACQUISITN COR | $1,034 | 0.00% | 13,144 | Common | SOLE |
| 462837113 | UCFIW | IRON HORSE ACQUISITIONS CORP | $875 | 0.00% | 25,000 | Common | SOLE |
| 20678X106 | — | CONDUIT PHARMACEUTICALS INC | $768 | 0.00% | 11,200 | Common | SOLE |
| 36119D111 | FTIIW | FUTURETECH II ACQUISITION CO | $462 | 0.00% | 30,000 | Common | SOLE |
| G3034H125 | EMCWF | EMBRACE CHANGE ACQUISITN COR | $241 | 0.00% | 18,000 | Common | SOLE |
| G0135E126 | AIMWF | AIMFINITY INVESTMENT CORP I | $126 | 0.00% | 18,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.